These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 19825996)
1. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis. Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996 [TBL] [Abstract][Full Text] [Related]
2. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis. Chen HY; Clayman ES; Ma WF J Interferon Cytokine Res; 2015 Oct; 35(10):771-8. PubMed ID: 25978539 [TBL] [Abstract][Full Text] [Related]
3. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Zeelenberg IS; Ruuls-Van Stalle L; Roos E Cancer Res; 2003 Jul; 63(13):3833-9. PubMed ID: 12839981 [TBL] [Abstract][Full Text] [Related]
4. [Construction of intrakine mutant SDF-1alpha/54/KDEL and its inhibiting effects upon CXCR4 expression on cell membrane]. Chen H; Tan Y; Guo Z; Ma W; Cai S; Du J; Huang J; Hu H; Cai S Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):647-51, 677. PubMed ID: 18693449 [TBL] [Abstract][Full Text] [Related]
5. Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma. Zeelenberg IS; Ruuls-Van Stalle L; Roos E J Clin Invest; 2001 Jul; 108(2):269-77. PubMed ID: 11457880 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Wendt MK; Cooper AN; Dwinell MB Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466 [TBL] [Abstract][Full Text] [Related]
7. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies. Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150 [TBL] [Abstract][Full Text] [Related]
8. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies. Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206 [TBL] [Abstract][Full Text] [Related]
9. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells. Sung B; Jhurani S; Ahn KS; Mastuo Y; Yi T; Guha S; Liu M; Aggarwal BB Cancer Res; 2008 Nov; 68(21):8938-44. PubMed ID: 18974138 [TBL] [Abstract][Full Text] [Related]
10. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma. Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285 [TBL] [Abstract][Full Text] [Related]
12. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells]. Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195 [TBL] [Abstract][Full Text] [Related]
13. CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells. Jones J; Marian D; Weich E; Engl T; Wedel S; Relja B; Jonas D; Blaheta RA Exp Cell Res; 2007 Nov; 313(19):4051-65. PubMed ID: 17706641 [TBL] [Abstract][Full Text] [Related]
14. A novel recombinant protein TAT-GFP-KDEL with dual-function of penetrating cell membrane and locating at endoplasm reticulum. Ma WF; Chen HY; Du J; Tan Y; Cai SH J Drug Target; 2009 May; 17(4):329-33. PubMed ID: 19558358 [TBL] [Abstract][Full Text] [Related]
15. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. Schabath H; Runz S; Joumaa S; Altevogt P J Cell Sci; 2006 Jan; 119(Pt 2):314-25. PubMed ID: 16390867 [TBL] [Abstract][Full Text] [Related]
16. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer. Huang EH; Singh B; Cristofanilli M; Gelovani J; Wei C; Vincent L; Cook KR; Lucci A J Surg Res; 2009 Aug; 155(2):231-6. PubMed ID: 19482312 [TBL] [Abstract][Full Text] [Related]
17. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Holland JD; Kochetkova M; Akekawatchai C; Dottore M; Lopez A; McColl SR Cancer Res; 2006 Apr; 66(8):4117-24. PubMed ID: 16618732 [TBL] [Abstract][Full Text] [Related]
18. HIV-1-Tat potentiates CXCL12/stromal cell-derived factor 1-induced downregulation of membrane CXCR4 in T lymphocytes through protein kinase C zeta. Hidalgo-Estévez AM; Punzón C; Sanchez-Duffhues G; Muñoz E; Fresno M Mol Immunol; 2008 Nov; 46(1):106-15. PubMed ID: 18760839 [TBL] [Abstract][Full Text] [Related]
19. Loss of C-terminal alpha-helix decreased SDF-1alpha-mediated signaling and chemotaxis without influencing CXCR4 internalization. Cai SH; Tan Y; Ren XD; Li XH; Cai SX; Du J Acta Pharmacol Sin; 2004 Feb; 25(2):152-60. PubMed ID: 14769202 [TBL] [Abstract][Full Text] [Related]
20. Intrakines--evidence for a trans-cellular mechanism of action. Engel BC; Bauer G; Pepper KA; Bockstoce DC; Yu XJ; Chen SY; Kohn DB Mol Ther; 2000 Feb; 1(2):165-70. PubMed ID: 10933927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]